Oral Health and Endometriosis: A Cohort Study
Launched by UNIVERSITY OF BARI ALDO MORO · Dec 21, 2024
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
The questions were structured thanks to the collaboration of expert health professionals: gynecologist, dentist, dental hygienist, physiotherapist, dietician, psychologist to obtain targeted information on endometriosis, on the type of therapy, on any signs and symptoms in the oral cavity (perception health status, presence of periodontal problems), to investigate oral hygiene and dietary habits, physical activity, quality of life, the presence of other immune-based diseases. In the final part of the questionnaire there was a section in which women were free to tell their stories.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • The only inclusion criterion was being at least 18 years old
- Exclusion Criteria:
- • • Pregnancy.
- • Administration of antibiotics in the last 15 days prior to entry into the study or indications for antibiotic prophylaxis.
- • Orthodontic Appliances.
- • Immunological diseases or use of drugs that can affect oral tissues (phenytoin, cyclosporine), nifedipine, chronic use of nonsteroidal anti-inflammatory drugs.
- • Refusal to participate in the study.
About University Of Bari Aldo Moro
The University of Bari Aldo Moro, a prominent academic institution located in Bari, Italy, is dedicated to advancing medical research and education. Renowned for its commitment to innovation and excellence, the university actively engages in clinical trials aimed at enhancing healthcare outcomes and contributing to the scientific community. With a multidisciplinary approach, the University of Bari collaborates with various stakeholders, including healthcare professionals and industry partners, to conduct rigorous research that addresses critical health challenges. Its clinical trial initiatives reflect a dedication to improving patient care and fostering a deeper understanding of medical conditions through evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bari, , Italy
Patients applied
Trial Officials
Saverio Capodiferro, Professor
Study Director
University of Bari Aldo Moro
Massimo Corsalini, Professor
Study Director
University of Bari Aldo Moro
Giuseppe D'Albis
Principal Investigator
University of Bari Aldo Moro
Agneta Maria Teresa
Principal Investigator
University of Bari Aldo Moro
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported